{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:14Z","timestamp":1787020934403,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Generation and use of human macrophages in vitro are essential for a variety of (therapeutic) applications. Recently, there has been growing interest in macrophages derived from induced pluripotent stem cells (iPSC-Mac), which has led to the development of numerous differentiation protocols. These protocols typically involve a stepwise differentiation process using well-defined culture media, though the final differentiation stage often relies on undefined animal serum components, such as fetal bovine serum (FBS). This study aimed to elucidate protocol-dependent effects on iPSC-Mac usability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed the impact of a serum-supplemented medium (RPMI\u2009+\u2009FBS) compared to a fully defined medium (X-VIVO 15\u2122) on the function of terminally differentiated human iPSC-Mac. Upon harvest, the cells were differentiated for three to four days in the respective media. Subsequently, phenotypic analysis was performed by microscopy and flow cytometry, as well as transcriptome and proteome analysis. Functional responsiveness to stimuli such as polarizing cytokines and lipopolysaccharide (LPS) was evaluated using flow cytometry and ELISA assay. The pharmaceutical screening potential was examined using secondary stimuli with dexamethasone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While both media compositions effectively produced fully functional human macrophages, we observed significant differences in their stage of activation and their functional responsiveness. Macrophages differentiated under the defined, serum-free conditions showed a more neutral activation state, an enhanced cholesterol metabolism, and were more sensitive to post pro- or anti-inflammatory stimulation compared to serum-grown cells. Most important, iPSC-Mac from these cultures also exhibit a more robust and reproducible response to co-stimulatory signals with IFN\u03b3 or LPS in combination with the immune-suppressive agent dexamethasone. In contrast, serum-grown iPSC-Mac demonstrated a more pre-activated state, with noteworthy background levels of interleukin 6 (IL-6). Upon stimulation, these cells showed reduced sensitivity and responsiveness towards secondary signals, underscoring potential challenges when using FBS-based media for drug screening or immunomodulatory assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The enhanced responsiveness to co-stimulatory signals makes iPSC-Mac from defined cultures more suitable for testing immunomodulatory drugs, novel bio-assays and in vivo applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-026-05009-1","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:36:05Z","timestamp":1775871365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Defined culture conditions improve functional properties of mature iPSC-derived macrophages for therapeutic screening"],"prefix":"10.1186","volume":"17","author":[{"given":"Maximilian","family":"Schinke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Gensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane Hai Ha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortense","family":"Slevogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"J\u00e4nsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-1497","authenticated-orcid":false,"given":"Nico","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"5009_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355. https:\/\/doi.org\/10.1038\/nature12034.","journal-title":"Nature"},{"key":"5009_CR2","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","volume":"185","author":"MD Park","year":"2022","unstructured":"Park MD, Silvin A, Ginhoux F, Merad M. Macrophages in health and disease. Cell. 2022;185:4259\u201379. https:\/\/doi.org\/10.1016\/j.cell.2022.10.007.","journal-title":"Cell"},{"key":"5009_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02247-1","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, et al Macrophages in organ fibrosis: from pathogenesis to therapeutic targets. Cell death discovery. 2024. . https:\/\/doi.org\/10.1038\/s41420-024-02247-1.","journal-title":"Cell death discovery"},{"key":"5009_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5.","journal-title":"Nat Rev Drug Discov"},{"key":"5009_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491. https:\/\/doi.org\/10.3389\/fimmu.2014.00491.","journal-title":"Front Immunol"},{"key":"5009_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","volume":"165\u2013166","author":"W He","year":"2020","unstructured":"He W, Kapate N, Shields CW, Mitragotri S. Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases. Adv Drug Deliv Rev. 2020;165\u2013166:15\u201340. https:\/\/doi.org\/10.1016\/j.addr.2019.12.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"5009_CR7","doi-asserted-by":"publisher","first-page":"1080310","DOI":"10.3389\/fimmu.2023.1080310","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Zhao M, Jia S, Macrophage. Key player in the pathogenesis of autoimmune diseases. Front Immunol. 2023;14:1080310. https:\/\/doi.org\/10.3389\/fimmu.2023.1080310.","journal-title":"Front Immunol"},{"key":"5009_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/hum.2020.235","volume":"32","author":"J Sens","year":"2021","unstructured":"Sens J, et al. Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies. Hum Gene Ther. 2021;32:77\u201395. https:\/\/doi.org\/10.1089\/hum.2020.235.","journal-title":"Hum Gene Ther"},{"key":"5009_CR9","doi-asserted-by":"publisher","first-page":"1397886","DOI":"10.3389\/fimmu.2024.1397886","volume":"15","author":"R Gonzalez","year":"2024","unstructured":"Gonzalez R. Human CFTR deficient iPSC-macrophages reveal impaired functional and transcriptomic response upon Pseudomonas aeruginosa infection. Front Immunol. 2024;15:1397886. https:\/\/doi.org\/10.3389\/fimmu.2024.1397886.","journal-title":"Front Immunol"},{"key":"5009_CR10","doi-asserted-by":"publisher","first-page":"e14704","DOI":"10.14814\/phy2.14704","volume":"9","author":"C Venter","year":"2021","unstructured":"Venter C, Myburgh KH, Niesler CU. Co-culture of pro-inflammatory macrophages and myofibroblasts: Evaluating morphological phenotypes and screening the effects of signaling pathway inhibitors. Physiological Rep. 2021;9:e14704. https:\/\/doi.org\/10.14814\/phy2.14704.","journal-title":"Physiological Rep"},{"key":"5009_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007705","author":"SM Abdin","year":"2023","unstructured":"Abdin SM, et al Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia. J Immunother Cancer. 2023. . https:\/\/doi.org\/10.1136\/jitc-2023-007705.","journal-title":"J Immunother Cancer"},{"key":"5009_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113616","author":"AT Song","year":"2024","unstructured":"Song AT, et al Developmental role of macrophages modeled in human pluripotent stem cell-derived intestinal tissue. Cell Rep. 2024. . https:\/\/doi.org\/10.1016\/j.celrep.2023.113616.","journal-title":"Cell Rep"},{"key":"5009_CR13","doi-asserted-by":"publisher","first-page":"101444","DOI":"10.1016\/j.jcmgh.2024.101444","volume":"19","author":"K Tominaga","year":"2024","unstructured":"Tominaga K, et al. Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem Cells. Cell Mol Gastroenterol Hepatol. 2024;19:101444. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101444.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5009_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0164-2","author":"M Wiemann","year":"2016","unstructured":"Wiemann M, et al An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials. J Nanobiotechnol. 2016. . https:\/\/doi.org\/10.1186\/s12951-016-0164-2.","journal-title":"J Nanobiotechnol"},{"key":"5009_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001589","author":"M Tapak","year":"2023","unstructured":"Tapak M, Sadeghi S, Ghazanfari T, Mosaffa N Chemical exposure and alveolar macrophages responses: \u2018the role of pulmonary defense mechanism in inhalation injuries\u2019. BMJ open respiratory Res. 2023. . https:\/\/doi.org\/10.1136\/bmjresp-2022-001589.","journal-title":"BMJ open Respirat Res"},{"key":"5009_CR16","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad4744","author":"SM Abdin","year":"2024","unstructured":"Abdin SM, et al. Sensor macrophages derived from human induced pluripotent stem cells to assess pyrogenic contaminations in parenteral drugs. Biofabrication. 2024. https:\/\/doi.org\/10.1088\/1758-5090\/ad4744.","journal-title":"Biofabrication"},{"key":"5009_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.06.017","volume":"47","author":"K Takata","year":"2017","unstructured":"Takata K, et al. Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function. Immunity. 2017;47:183\u2013e1986. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.017.","journal-title":"Immunity"},{"key":"5009_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07570-7","author":"M Ackermann","year":"2018","unstructured":"Ackermann M, et al Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nat Commun. 2018. . https:\/\/doi.org\/10.1038\/s41467-018-07570-7.","journal-title":"Nat Commun"},{"key":"5009_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134808","author":"S Gutbier","year":"2020","unstructured":"Gutbier S, et al. Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21134808.","journal-title":"Int J Mol Sci"},{"key":"5009_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416087","author":"A Klepikova","year":"2022","unstructured":"Klepikova A, et al. iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232416087.","journal-title":"Int J Mol Sci"},{"key":"5009_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00824-4","author":"I Lyadova","year":"2022","unstructured":"Lyadova I, Vasiliev A Macrophages derived from pluripotent stem cells: prospective applications and research gaps. Cell bioscience. 2022. . https:\/\/doi.org\/10.1186\/s13578-022-00824-4.","journal-title":"Cell bioscience"},{"key":"5009_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03785-2","author":"M Ackermann","year":"2024","unstructured":"Ackermann M, et al Standardized generation of human iPSC-derived hematopoietic organoids and macrophages utilizing a benchtop bioreactor platform under fully defined conditions. Stem Cell Res Ther. 2024. . https:\/\/doi.org\/10.1186\/s13287-024-03785-2.","journal-title":"Stem Cell Res Ther"},{"key":"5009_CR23","doi-asserted-by":"publisher","DOI":"10.3791\/61038","author":"M Lopez-Yrigoyen","year":"2020","unstructured":"Lopez-Yrigoyen M, et al. Production and Characterization of Human Macrophages from Pluripotent Stem Cells. J visualized experiments: JoVE. 2020. https:\/\/doi.org\/10.3791\/61038.","journal-title":"J visualized experiments: JoVE"},{"key":"5009_CR24","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.stemcr.2021.05.018","volume":"16","author":"A Vaughan-Jackson","year":"2021","unstructured":"Vaughan-Jackson A, et al. Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium. Stem cell Rep. 2021;16:1735\u201348. https:\/\/doi.org\/10.1016\/j.stemcr.2021.05.018.","journal-title":"Stem cell Rep"},{"key":"5009_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/stem.3449","volume":"39","author":"S Pouyanfard","year":"2021","unstructured":"Pouyanfard S, et al. Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis. Stem Cells. 2021;39:1701\u201317. https:\/\/doi.org\/10.1002\/stem.3449.","journal-title":"Stem Cells"},{"key":"5009_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8060831","author":"A O\u2019Keeffe","year":"2020","unstructured":"O\u2019Keeffe A, et al. Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8060831.","journal-title":"Microorganisms"},{"key":"5009_CR27","doi-asserted-by":"publisher","first-page":"e0035324","DOI":"10.1128\/mbio.00353-24","volume":"15","author":"C Bussi","year":"2024","unstructured":"Bussi C, Lai R, Athanasiadi N, Gutierrez MG. Physiologic medium renders human iPSC-derived macrophages permissive for M. tuberculosis by rewiring organelle function and metabolism. mBio. 2024;15:e0035324. https:\/\/doi.org\/10.1128\/mbio.00353-24.","journal-title":"mBio"},{"key":"5009_CR28","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1002\/cpsc.74","volume":"48","author":"J Shi","year":"2019","unstructured":"Shi J, Xue C, Liu W, Zhang H. Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics. Curr Protoc Stem Cell Biol. 2019;48:e74. https:\/\/doi.org\/10.1002\/cpsc.74.","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"5009_CR29","doi-asserted-by":"publisher","first-page":"656867","DOI":"10.3389\/fcell.2021.656867","volume":"9","author":"Di Cui","year":"2021","unstructured":"Di Cui, et al. High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary Cells. Front cell Dev biology. 2021;9:656867. https:\/\/doi.org\/10.3389\/fcell.2021.656867.","journal-title":"Front cell Dev biology"},{"key":"5009_CR30","doi-asserted-by":"publisher","first-page":"e0243807","DOI":"10.1371\/journal.pone.0243807","volume":"15","author":"S Monkley","year":"2020","unstructured":"Monkley S, et al. Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts. PLoS ONE. 2020;15:e0243807. https:\/\/doi.org\/10.1371\/journal.pone.0243807.","journal-title":"PLoS ONE"},{"key":"5009_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.slasd.2023.04.002","volume":"28","author":"S Bitzer","year":"2023","unstructured":"Bitzer S, et al. Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay. SLAS discovery: Adv life Sci R D. 2023;28:149\u201362. https:\/\/doi.org\/10.1016\/j.slasd.2023.04.002.","journal-title":"SLAS discovery: Adv life Sci R D"},{"key":"5009_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-024-01553-8","author":"T Okada","year":"2024","unstructured":"Okada T, et al Phagocytosis model of calcium oxalate monohydrate crystals generated using human induced pluripotent stem cell-derived macrophages. Urolithiasis. 2024. . https:\/\/doi.org\/10.1007\/s00240-024-01553-8.","journal-title":"Urolithiasis"},{"key":"5009_CR33","doi-asserted-by":"publisher","first-page":"102827","DOI":"10.1016\/j.xpro.2023.102827","volume":"5","author":"TS Park","year":"2024","unstructured":"Park TS, et al. Differentiation of monocytes and polarized M1\/M2 macrophages from human induced pluripotent stem cells. STAR protocols. 2024;5:102827. https:\/\/doi.org\/10.1016\/j.xpro.2023.102827.","journal-title":"STAR protocols"},{"key":"5009_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stemcr.2019.08.008","volume":"13","author":"D Klatt","year":"2019","unstructured":"Klatt D, et al. Targeted Repair of p47-CGD in iPSCs by CRISPR\/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes. Stem cell Rep. 2019;13:590\u20138. https:\/\/doi.org\/10.1016\/j.stemcr.2019.08.008.","journal-title":"Stem cell Rep"},{"key":"5009_CR35","doi-asserted-by":"publisher","unstructured":"Liu S, Yang W, Li Y, Sun C. Fetal bovine serum, an important factor affecting the reproducibility of cell experiments. Sci Report. 2023;13:1942. https:\/\/doi.org\/10.1038\/s41598-023-29060-7.","DOI":"10.1038\/s41598-023-29060-7"},{"key":"5009_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2144\/btn-2020-0043","volume":"69","author":"N Yang","year":"2020","unstructured":"Yang N, Sin DD, Dorscheid DR. Various factors affect lipopolysaccharide sensitization in cell cultures. Biotechniques. 2020;69:126\u201332. https:\/\/doi.org\/10.2144\/btn-2020-0043.","journal-title":"Biotechniques"},{"key":"5009_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41590-022-01146-w","volume":"23","author":"S Subramanian","year":"2022","unstructured":"Subramanian S, et al. Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo. Nat Immunol. 2022;23:458\u201368. https:\/\/doi.org\/10.1038\/s41590-022-01146-w.","journal-title":"Nat Immunol"},{"key":"5009_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373. https:\/\/doi.org\/10.1038\/ng1180.","journal-title":"Nat Genet"},{"key":"5009_CR39","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41598-017-00828-y","volume":"7","author":"MM M\u00fcller","year":"2017","unstructured":"M\u00fcller MM, et al. Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNF\u03b1 expression. Sci Rep. 2017;7:838. https:\/\/doi.org\/10.1038\/s41598-017-00828-y.","journal-title":"Sci Rep"},{"key":"5009_CR40","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.regen.2022.100061","volume":"17","author":"M Schinke","year":"2022","unstructured":"Schinke M, et al. Polarization of human iPSC-derived macrophages directs their immunological response to secondary pro-inflammatory stimuli. J Immunol Regenerative Med. 2022;17:100061. https:\/\/doi.org\/10.1016\/j.regen.2022.100061.","journal-title":"J Immunol Regenerative Med"},{"key":"5009_CR41","doi-asserted-by":"publisher","first-page":"e0156323","DOI":"10.1128\/jvi.01563-23","volume":"98","author":"Q Yang","year":"2024","unstructured":"Yang Q, et al. Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses. J Virol. 2024;98:e0156323. https:\/\/doi.org\/10.1128\/jvi.01563-23.","journal-title":"J Virol"},{"key":"5009_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5483\/BMBRep.2017.50.2.011","volume":"50","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, Kim HM. Dynamic lipopolysaccharide transfer cascade to TLR4\/MD2 complex via LBP and CD14. BMB Rep. 2017;50:55\u20137. https:\/\/doi.org\/10.5483\/BMBRep.2017.50.2.011.","journal-title":"BMB Rep"},{"key":"5009_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/17534259221097948","volume":"28","author":"S Solati","year":"2022","unstructured":"Solati S, Zhang T, Timman S. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens. Innate Immun. 2022;28:130\u20137. https:\/\/doi.org\/10.1177\/17534259221097948.","journal-title":"Innate Immun"},{"key":"5009_CR44","doi-asserted-by":"publisher","first-page":"e42656","DOI":"10.1371\/journal.pone.0042656","volume":"7","author":"F Rey-Giraud","year":"2012","unstructured":"Rey-Giraud F, Hafner M, Ries CH. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS ONE. 2012;7:e42656. https:\/\/doi.org\/10.1371\/journal.pone.0042656.","journal-title":"PLoS ONE"},{"key":"5009_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/026119291704500611","volume":"45","author":"J van der Valk","year":"2017","unstructured":"van der Valk J, Gstraunthaler G. Fetal Bovine Serum (FBS) - A pain in the dish? Altern Lab animals: ATLA. 2017;45:329\u201332. https:\/\/doi.org\/10.1177\/026119291704500611.","journal-title":"Altern Lab animals: ATLA"},{"key":"5009_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yexcr.2018.02.017","volume":"365","author":"JI Heger","year":"2018","unstructured":"Heger JI, et al. Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum. Exp Cell Res. 2018;365:57\u201365. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.017.","journal-title":"Exp Cell Res"},{"key":"5009_CR47","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41598-020-80540-6","volume":"11","author":"W-H Tang","year":"2021","unstructured":"Tang W-H, Wang C-F, Liao Y-D. Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with \u03b11-antitrypsin. Sci Rep. 2021;11:1267. https:\/\/doi.org\/10.1038\/s41598-020-80540-6.","journal-title":"Sci Rep"},{"key":"5009_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0014-4827(85)90173-9","volume":"160","author":"EG Hayman","year":"1985","unstructured":"Hayman EG, Pierschbacher MD, Suzuki S, Ruoslahti E. Vitronectin\u2014a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res. 1985;160:245\u201358. https:\/\/doi.org\/10.1016\/0014-4827(85)90173-9.","journal-title":"Exp Cell Res"},{"key":"5009_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00418-017-1571-7","volume":"148","author":"M Verdanova","year":"2017","unstructured":"Verdanova M, Sauerova P, Hempel U, Kalbacova MH. Initial cell adhesion of three cell types in the presence and absence of serum proteins. Histochem Cell Biol. 2017;148:273\u201388. https:\/\/doi.org\/10.1007\/s00418-017-1571-7.","journal-title":"Histochem Cell Biol"},{"key":"5009_CR50","doi-asserted-by":"publisher","first-page":"1349461","DOI":"10.3389\/fimmu.2024.1349461","volume":"15","author":"S Piatnitskaia","year":"2024","unstructured":"Piatnitskaia S, et al. Modelling of macrophage responses to biomaterials in vitro: state-of-the-art and the need for the improvement. Front Immunol. 2024;15:1349461. https:\/\/doi.org\/10.3389\/fimmu.2024.1349461.","journal-title":"Front Immunol"},{"key":"5009_CR51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ni.3818","volume":"18","author":"SH Park","year":"2017","unstructured":"Park SH, et al. Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nat Immunol. 2017;18:1104\u201316. https:\/\/doi.org\/10.1038\/ni.3818.","journal-title":"Nat Immunol"},{"key":"5009_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCRESAHA.108.182568","volume":"104","author":"Y Sun","year":"2009","unstructured":"Sun Y, et al. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circul Res. 2009;104:455\u201365. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.182568.","journal-title":"Circul Res"},{"key":"5009_CR53","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1074\/jbc.M117.796631","volume":"293","author":"H Tsukamoto","year":"2018","unstructured":"Tsukamoto H, et al. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKK\u03f5-IRF3 axis activation. J Biol Chem. 2018;293:10186\u2013201. https:\/\/doi.org\/10.1074\/jbc.M117.796631.","journal-title":"J Biol Chem"},{"key":"5009_CR54","doi-asserted-by":"publisher","first-page":"e0316203","DOI":"10.1371\/journal.pone.0316203","volume":"19","author":"K Hayashi","year":"2024","unstructured":"Hayashi K, et al. Evaluation of the effect of cell freshness on pyrogen detection using a serum-free monocyte-activation test. PLoS ONE. 2024;19:e0316203. https:\/\/doi.org\/10.1371\/journal.pone.0316203.","journal-title":"PLoS ONE"},{"key":"5009_CR55","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbamcr.2016.01.015","volume":"1863","author":"F Kopp","year":"2016","unstructured":"Kopp F, Kupsch S, Schromm AB. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of LBP in intracellular LPS-signaling. Biochim Biophys Acta. 2016;1863:660\u201372. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.015.","journal-title":"Biochim Biophys Acta"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05009-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:09:40Z","timestamp":1776078580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05009-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5009"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05009-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generation of the human iPSC line \u2018hCD34iPSC11\u2019 (iPSC line #1) has been performed at the Hannover Medical School. The patient provided written informed consent, and the generation and usage were approved by the ethics committee of the Hannover Medical School \u2013 project no. 2519\u2009\u2212\u20092014 for sample collection entitled \u201cSpende von Blutpl\u00e4ttchen (Thrombozyten) und Plasma am Zellseparator (Thrombozytapharese)\u201d in the year 2014 and project no. 7870_BO_K_2018 for iPSC generation entitled \u201cThe regenerative potential of ex vivo generated macrophages for new cell-based therapies\u201d in 2018. \u2018SCTi003-A\u2019 (iPSC line #2) was generated by STEMCELL Technologies and was purchased for this study. Informed consent has been obtained from the donor by STEMCELL Technologies. The studies were conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N.L. is an author of the patent application (European patent application number PCT\/EP2018\/061574) entitled \u2018Stem-cell derived myeloid cells, generation and use thereof\u2019. The priority date of the application is 4 May 2017. N.L. is an author on the patent application (European patent application number PCT\/EP2021\/083371) entitled \u2018Application of stem cell derived monocytes in a Monocyte Activation Test (MAT) for the assessment of pyrogenicity and inflammatory potential\u2019. The priority date of the application is 29 November 2021. N.L. receives research funding from Novo Nordisk and holds a consultancy agreement with Evotec (scope outside the manuscript)All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}